Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.
about
Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challengesOvercoming drug efflux-based multidrug resistance in cancer with nanotechnologyNanoemulsions in translational research-opportunities and challenges in targeted cancer therapyCancer stem cells and drug resistance: the potential of nanomedicineEnabling anticancer therapeutics by nanoparticle carriers: the delivery of PaclitaxelEGF receptor-targeted nanocarriers for enhanced cancer treatmentTherapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancerLabel-Free Raman Microspectral Analysis for Comparison of Cellular Uptake and Distribution between Non-Targeted and EGFR-Targeted Biodegradable Polymeric Nanoparticles99mTc-radiolabeled GE11-modified peptide for ovarian tumor targeting.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyDevelopment of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancerMad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model.Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy.Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian CancerPolymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicinPolydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapyLipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot studyTargeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast CancerTargeting the metabolic microenvironment of tumors.Membrane proteins: the key players of a cancer cell.Recent trends in cancer drug resistance reversal strategies using nanoparticles.Image-guided nanosystems for targeted delivery in cancer therapy.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Nanopreparations to overcome multidrug resistance in cancer.Nanomaterials for targeted drug delivery to cancer stem cells.Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy.Chemical Protein Modification through Cysteine.The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.Cytotoxic enhancement of hexapeptide-conjugated micelles in EGFR high-expressed cancer cells.EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.Improved Targeting of Cancers with Nanotherapeutics.Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian cancer cells.Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.The potential of multi-compound nanoparticles to bypass drug resistance in cancer.GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview.Synergistic Anticancer Effect of Peptide-Docetaxel Nanoassembly Targeted to Tubulin: Toward Development of Dual Warhead Containing Nanomedicine.Energy restriction: stepping stones towards cancer therapy.
P2860
Q26827820-98366595-316A-423C-AE19-B924F0D11D09Q26849264-798F0DA6-4A74-4481-9E10-807131A5E2E7Q26858849-C6143AEE-EBA2-4647-8C12-743EF06F255BQ26998993-261D2191-1FD4-4D54-B696-0048C7307454Q26999288-970EF648-31DE-4E53-8E6C-B983252C0005Q27013001-ED756AC0-FAF1-49BA-A546-32991FE76FAEQ28476850-C171F8C4-1092-485C-B4A0-1D2682C32A5DQ30558038-5DB04037-36AD-4F12-891D-69D4188AD9F2Q33630303-5150C72A-BE55-4929-8F73-979861AE6BC2Q33859472-FE7E5F08-CD9C-462E-AFA1-01D3118CB54CQ34214594-CED95085-7455-4C63-B250-21CCB7A58D5DQ34293616-7025CF09-F034-4690-92F9-AC8484BE4C68Q35106014-16FBEC29-9384-4110-A606-B80763F1EE07Q35812462-A19D9E82-AEFF-4EAA-9EB3-2DA3FE51BF81Q35836455-A4C396A3-75EB-4A3D-BDD5-13BCB46D8D14Q36207113-4540EB07-AC98-41B6-BC58-6024645CC082Q36489491-85517924-EF52-4BA8-B2A9-A725EB9B68B6Q36585890-4F932140-3795-4A66-893F-710320FFF17AQ36680180-E0F8EF49-2E0C-497E-B97A-EE3B23C8818DQ36917747-A4426FC5-EDD9-4DFB-AC71-E0E448B085F3Q37229190-998C3AFC-2E42-4EAB-AE69-EBAE941327CDQ37898014-B1111A04-D882-45C9-9C9B-67C8CEDCBA5DQ37984588-429B870C-62A4-48A2-8881-0637BB7782B0Q38011794-13FD6C93-CBB9-488F-B9D4-3892110C9D4EQ38067265-34E405D2-8947-4B7D-A637-BF714EB3C712Q38131264-84A4162E-F0D8-4CE0-97E3-388D8CEAF914Q38201740-D08ED92E-F1C1-49D1-ABE5-3DDE1E58F8DDQ38584742-8B387BF3-0872-4345-B867-C0D3EE5CEFCFQ38704033-04B83743-E615-42AD-8848-5415A8F4CF26Q38809044-DF00FEE2-B51F-4374-A775-7A44413E1D16Q38982625-B5426835-810A-4706-B203-A79CAA152B60Q39011609-8494C7BB-4AA8-45F7-905A-343A4FA2FF21Q39114835-26A8AE7B-2661-4AE7-9616-250D0C9A2264Q39338877-32E9C38E-99C1-4C4D-AD46-C536961A2ACBQ42373834-F296538A-3DEE-42E6-9473-9144E77A9EAAQ47114290-CAD1C636-6827-4B48-82F7-DD947F6E20FCQ48356798-5F48B3EB-20FC-458C-9A32-4629D4F71538Q51362699-32AC6E32-2B77-45E4-89F7-3DC7B1771889Q51532832-BFE737C2-9C0B-45EA-8B31-E5772162576D
P2860
Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Development of EGFR-targeted p ...... reast and ovarian tumor cells.
@en
Development of EGFR-targeted p ...... reast and ovarian tumor cells.
@nl
type
label
Development of EGFR-targeted p ...... reast and ovarian tumor cells.
@en
Development of EGFR-targeted p ...... reast and ovarian tumor cells.
@nl
prefLabel
Development of EGFR-targeted p ...... reast and ovarian tumor cells.
@en
Development of EGFR-targeted p ...... reast and ovarian tumor cells.
@nl
P2093
P2860
P356
P1476
Development of EGFR-targeted p ...... reast and ovarian tumor cells.
@en
P2093
Lara Milane
Mansoor Amiji
Zhenfeng Duan
P2860
P304
P356
10.1021/MP1002653
P407
P577
2010-11-24T00:00:00Z